Table 1. Median survival for patients with NSCLC since the beginning of the NLCA (n=120 745).
| Years | Number of patients reported | Median survival in days | IQR in days | Number of patients surviving >1 year (%) |
|---|---|---|---|---|
| Whole cohort |
120 745 |
189 |
58–547 |
40 921 (33.89) |
| 2004/2005 |
15 267 |
193 |
61–558 |
5271 (34.53) |
| 2006 |
15 252 |
193 |
60–544 |
5306 (34.18) |
| 2007 |
18 193 |
189 |
58–533 |
6110 (33.58) |
| 2008 |
21 860 |
182 |
56–522 |
7240 (33.12) |
| 2009 |
25 072 |
186 |
57–546 |
8559 (34.14) |
| 2010 | 24 828 | 182 | 55–585 | 8435 (33.97) |
Abbreviation: IQR=interquartile range.